Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder

Molecular and Clinicopathological Analysis of Epstein-Barr Virus-Associated Posttransplant Smooth Muscle Tumors

(2012) D. Jonigk et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report

(2012) T. G. Gross et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

(2012) S. Caillard et al.   AMERICAN JOURNAL OF TRANSPLANTATION

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency

(2012) Kasandra J Riley et al.   EMBO JOURNAL

Monitoring Infection with Epstein-Barr Virus among Seromismatch Adult Renal Transplant Recipients

(2011) S. I. Martin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

(2011) R. Reshef et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Bortezomib induction of C/EBP  mediates Epstein-Barr virus lytic activation in Burkitt lymphoma

(2011) C. M. Shirley et al.   BLOOD

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

(2010) A. Durrbach et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Primary central nervous system post-transplantation lymphoproliferative disorder

(2010) Robert Cavaliere et al.   CANCER

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up

(2010) Tanzina Haque et al.   TRANSPLANTATION

An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients

(2010) Josep Grinyó et al.   TRANSPLANTATION

Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

(2009) U. Allen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Interlaboratory Comparison of Epstein-Barr Virus Viral Load Assays

(2009) J. K. Preiksaitis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Intestinal transplantation: current outcomes and opportunities

(2009) George V Mazariegos   Current Opinion in Organ Transplantation

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy

(2009) Yuriko Fujita et al.   JOURNAL OF IMMUNOTHERAPY

The Impact of EBV Load on T-Cell Immunity in Pediatric Thoracic Transplant Recipients

(2009) Camila Macedo et al.   TRANSPLANTATION

A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

(2009) Lesley Rees et al.   TRANSPLANTATION

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two-Arm Prospective Trial

(2008) D. E. Tsai et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein-Barr viral loads

(2008) Elizabeth Schauer et al.   PEDIATRIC TRANSPLANTATION

T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic stem cell transplant

(2007) P. Comoli et al.   BLOOD CELLS MOLECULES AND DISEASES